All Names
AlternameCPLA2, Cytosolic phospholipase A2, EC 3.1.1.4, EC 3.1.1.5, PA24, PA24A, PLA2G4, PLA2G4A, Phosphatidylcholine 2-acylhydrolase
All SitesHuman: Ser505; Mouse: Ser505; Rat: Ser505
Form Or Antibody
Form of AntibodyRabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Storage/StabilityStore at -20℃/1 year
ImmunogenThe antiserum was produced against synthesized phosphopeptide derived from human c-PLA2 around the phosphorylation site of serine 505 (P-L-SP-P-L).
PurificationThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Specificty Sensitivity
Specificity/Sensitivityc-PLA2 (Phospho-Ser505) antibody detects endogenous levels of c-PLA2 only when phosphorylated at serine 505.
ReferencesD. D. Denson, J Neurophysiol, Jun 2005; 93: 3146 - 3156.
Diane M. Duffy, J. Clin. Endocrinol. Metab., Oct 2005; 90: 5858 - 5865.
Andrei I. Ivanov, Am J Physiol Regulatory Integrative Comp Physiol, Nov 2002; 283: 1104.
Miriam Kolko, Invest. Ophthalmol. Vis. Sci., Mar 2007; 48: 1401 - 1409.